CTCF and neoplasm: Stratifying the data by cancer type reduces the mutation counts in each category, but suggests that lung adenoma tumours (which also possess a distinctive mutational profile; S2 Table) may accumulate more mutations at functional TFBSs compared to other cancer types, with the notable exception of CTCF binding sites.